Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Multi-Center Trial of Zinc for the Treatment of Herpes Simplex Labialis (HSL)

NCT00809809 is registered in ClinicalTrials.gov with Integrative Medicine Institute as lead sponsor.

NCT NCT00809809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00809809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Multi-Center Trial of Zinc for the Treatment of Herpes Simplex Labialis (HSL)
Lead sponsor
Integrative Medicine Institute
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2008
Completion date
December 31, 2010
Enrollment
157 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

herpes simplex labialis